LM-102 Obtained FDA Clinical Trial Approval and Completed First Patient Dosing
-
2021-06-22
-
Share:
LM-102 obtained FDA clinical trial approval early this year as a phase I clinical study designed to evaluate the safety and initial efficacy of LM-102.